These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 14254831)
21. [Studies on the effect of urokinase on the fibrinolytic activity of the blood]. ANDREENKO GV; STRUKOVA SM Biokhimiia; 1962; 27():327-9. PubMed ID: 13861411 [No Abstract] [Full Text] [Related]
22. THROMBOLYTIC THERAPY. DOUGLAS AS; MCNICOL GP Proc R Soc Med; 1964 Jul; 57(7):609-14. PubMed ID: 14178954 [No Abstract] [Full Text] [Related]
23. [THE FIBRINOLYTIC THERAPY OF EXPERIMENTAL MASSIVE PULMONARY EMBOLISM IN RABBITS]. MATTIOLI G; RABITTI G; NAVA C Minerva Cardioangiol; 1964 Jan; 12():25-8. PubMed ID: 14130219 [No Abstract] [Full Text] [Related]
24. [Research on fibrinolysis: the fibrinolysis factors in Kline's plasminogen]. GIACOMAZZI G Haematol Lat; 1961; 4():339-70. PubMed ID: 13898267 [No Abstract] [Full Text] [Related]
25. THE EFFECT OF SOME PHYSIOLOGICAL STIMULI ON FIBRINOLYTIC ACTIVITY IN MAN MEASURED BY THE HEPARIN FRACTIONATION METHOD. THOMSON WB; GREEN J; EVANS IL J Clin Pathol; 1964 May; 17(3):341-4. PubMed ID: 14159819 [No Abstract] [Full Text] [Related]
26. THE EFFECT OF INDUCED FIBRINOLYSIS AND VARIOUS SUBSTANCES ON THE MAST CELLS IN THE PERITONEAL FLUID AND MESENTERY OF THE RAT. CRONBERG S; NILSSON IM Acta Pathol Microbiol Scand; 1964; 60():156-63. PubMed ID: 14121975 [No Abstract] [Full Text] [Related]
27. THE PROACTIVATOR (PLASMINOGEN?) DETERMINATION IN PLASMA DURING FIBRINOLYTIC THERAPY. BLIX S Acta Med Scand; 1964 Nov; 176():649-50. PubMed ID: 14223542 [No Abstract] [Full Text] [Related]
28. THE INFLUENCE OF FIBRINOGENOLYTIC AND FIBRINOLYTIC SPLIT PRODUCTS ON THE LAST STAGE OF COAGULATION. GODAL HC; HELLE I Scand J Clin Lab Invest; 1963; 15():327-30. PubMed ID: 14073280 [No Abstract] [Full Text] [Related]
29. [THROMBOLYTIC THERAPY. CLINICAL TRIALS OF TREATMENT WITH PURIFIED STREPTOKINASE]. ABASTADO M Bull Mem Soc Med Hop Paris; 1964 Jul; 115():941-57. PubMed ID: 14230879 [No Abstract] [Full Text] [Related]
30. [ON A METHOD FOR THE DETERMINATION OF PLASMA FIBRINOLYTIC ACTIVITY]. SHIRAI T Klin Wochenschr; 1964 Jun; 42():586-8. PubMed ID: 14236987 [No Abstract] [Full Text] [Related]
31. EVALUATION OF THE FIBRINOLYTIC STATE AFTER ADMINISTRATION OF UROKINASE. BAUMGARTEN W; PRIESTER LI; HERCZEG SA; WATSON LS Proc Soc Exp Biol Med; 1964 Apr; 115():1120-4. PubMed ID: 14166574 [No Abstract] [Full Text] [Related]
32. [APROPOS OF THROMBOLYTIC THERAPY]. DONNER L Cas Lek Cesk; 1964 Jan; 103():102-7. PubMed ID: 14129510 [No Abstract] [Full Text] [Related]
33. Effects of epsilon-amino-caproic acid on prolactin-inactivating and fibrinolytic activities of streptokinase-activated plasminogen. HOPKINS TF; MEITES J Proc Soc Exp Biol Med; 1963 Apr; 112():830-2. PubMed ID: 13961684 [No Abstract] [Full Text] [Related]
35. SOME PROPERTIES OF THE ANTIFIBRINOLYTICALLY ACTIVE ISOMER OF AMINO-METHYLCYCLOHEXANE CARBOXYLIC ACID. DUBBER AH; MCNICOL GP; DOUGLAS AS; MELANDER B Lancet; 1964 Dec; 2(7373):1317-9. PubMed ID: 14224037 [No Abstract] [Full Text] [Related]
36. IN VIVO ACTIVATION OF THE FIBRINOLYTIC SYSTEM OF THE CAT. EFFECT OF STREPTOKINASE, TRYPSIN AND GLYCEROL. FLEMING LB; CLIFFTON EE J Surg Res; 1965 Apr; 5():153-65. PubMed ID: 14279210 [No Abstract] [Full Text] [Related]
37. IMMUNOHISTOCHEMICAL STUDY OF THROMBOLYTIC MECHANISMS. BACK N; HIRAMOTO R; AMBRUS JL Blood; 1965 Jun; 25():1028-36. PubMed ID: 14294764 [No Abstract] [Full Text] [Related]
39. THROMBOLYTIC THERAPY. DOUGLAS AS; MCNICOL GP Br Med Bull; 1964 Sep; 20():228-32. PubMed ID: 14209763 [No Abstract] [Full Text] [Related]
40. THE EFFECT OF COPPER IONS ON CLOT LYSIS TIME IN THE FIBRINOLYTIC ASSAY OF STREPTOKINASE. BOGERT AB Thromb Diath Haemorrh; 1965 Jun; 13():477-83. PubMed ID: 14347869 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]